A3.20 The calcium sensor stromal interaction molecule 1 (STIM1) controls regulatory B cell functions and its activity is impaired in Systemic Lupus Erythematosus patients.

Abstract : BACKGROUND AND OBJECTIVES: The immunosuppressive function of regulatory B cells (Breg) is defective in B cells from systemic lupus erythematosus (SLE) patients. Since the Ca(2+) pathway is also altered in SLE B cells, the aim of the study was to explore the contribution of the Ca(2+) channel Orai1 and its regulator, the stromal interaction molecule 1 (STIM1), on regulatory B cell functions. MATERIALS AND METHODS: Thirty SLE patients and healthy controls (HC) were included in the study. Orai1 and STIM1 expressions were explored in CD40/CpG activated B cells, and in the stimulated (anti-CD3, anti-CD28 plus CpG-ODN 2006) T- and B- cell autologous co-culture Breg model. Transfection were used using either siRNAs to down-modulate STIM1 in SLE B cells, or either the cDNA STIM1 vector in HC B cells. RESULTS: After 3 days, in CD40/CpG activated HC B cells, and in HC B cells stimulated during co-cultures, acquisition of the Breg phenotype (IgD/CD38/CD24/CD5(high)) was associated with an over-expression of the Ca(2+) regulator STIM1 (x10.8 and x7.1 fold increase respectively). At day 4 and even more at day 5, STIM1 expression declined in co-cultures and this down-regulation was accompanied with IL-10 and TGF-beta up-regulation in B cells, FoxP3(+) regulatory T cell expansion, and a reduction of T cell proliferation. Expression of the Ca(2+) channel Orai1 was stable. In SLE B cells, STIM1 expression was overexpressed at basal level when compared to HC B cells (x4.3 fold) and remains elevated in B cells during all the time of the autologous co-culture (x8.8 fold). Then we hypothesised that maintaining high levels of STIM1 was critic in the regulatory capacity of SLE B cells. Accordingly, we demonstrated that STIM1 downregulation in SLE B cells, using a specific siRNA, was effective to restore IL-10, but not TGF-beta, expression, FoxP3(+) regulatory SLE T cell expansion, and SLE T cell inhibition. In HC B cells, forcing STIM1 expression, with a STIM1 vector, was effective to reproduce the abnormalities observed in SLE B cells. No association was observed between STIM1 expression at basal level and organ involvement, disease activity (SLEDAI), or serological parameters thus suggesting that STIM1 over-expression and Ca(2+) dysregulations are primary events in SLE. CONCLUSIONS: Altogether, this study reveals that acquisition of the Breg phenotype and Breg functions are tightly regulated by STIM1. Furthermore, this observation could provide innovative B-cell based treatment to convert B cells into immunosuppressive cells with applications in human autoimmunity and in SLE. KEY WORDS: lupus, regulatory B cells, calcium, STIM1, IL-10.
Type de document :
Article dans une revue
Annals of the Rheumatic Diseases, BMJ Publishing Group, 2014, 73 Suppl 1, pp.A49-50. 〈10.1136/annrheumdis-2013-205124.113〉
Liste complète des métadonnées

http://hal.univ-brest.fr/hal-00950030
Contributeur : Geneviève Michel <>
Soumis le : jeudi 20 février 2014 - 15:35:40
Dernière modification le : mardi 30 janvier 2018 - 10:42:01

Identifiants

Collections

Citation

T. Fali, Y. Renaudineau, M. Burgos, E. Bariller, S. Jousse, et al.. A3.20 The calcium sensor stromal interaction molecule 1 (STIM1) controls regulatory B cell functions and its activity is impaired in Systemic Lupus Erythematosus patients.. Annals of the Rheumatic Diseases, BMJ Publishing Group, 2014, 73 Suppl 1, pp.A49-50. 〈10.1136/annrheumdis-2013-205124.113〉. 〈hal-00950030〉

Partager

Métriques

Consultations de la notice

203